Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Safety and Efficacy of Stem Cell Therapy for Diabetic Peripheral Neuropathy in Animal Studies: A Systematic Review and Meta-Analysis Publisher Pubmed



Alizadeh SD1 ; Hassan Zadeh Tabatabaei MS1 ; Rezaei Zadeh Rukerd M2 ; Tabrizi R3 ; Masoomi R1 ; Banihashemian SZ4 ; Pourmasjedi SS1 ; Ghodsi Z1 ; Pourrashidi A5, 6 ; Harrop J7 ; Rahimimovaghar V1, 8
Authors
Show Affiliations
Authors Affiliations
  1. 1. Sina Trauma and Surgery Research Center, Tehran University of Medical Sciences, Tehran, Iraq
  2. 2. Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iraq
  3. 3. Noncommunicable Diseases Research Center, Fasa University of Medical Science, Fasa, Iraq
  4. 4. Student Research Committee, Faculty of Medicine, Semnan University of Medical Sciences, Semnan, Iraq
  5. 5. Department of Neurosurgery, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iraq
  6. 6. Founder of Neurosurgical Research Network, Universal Scientific Education and Research Network, Tehran, Iraq
  7. 7. Department of Neurosurgery, Thomas Jefferson University, Philadelphia, PA, United States
  8. 8. Universal Scientific Education and Research Network, Tehran, Iraq

Source: Neuroscience Published:2025


Abstract

Diabetic peripheral neuropathy (DPN) is the most common form of diabetic neuropathy, representing 75% of cases and posing a substantial public health challenge. Emerging evidence from animal studies indicates that stem cell therapy holds significant promise as a potential treatment for diabetic neuropathy. Nevertheless, a comprehensive evaluation of the safety and efficacy of stem cell therapy for DPN in animal studies remains outstanding. A systematic search of MEDLINE, Embase, Scopus, the Web of Science, and the CENTRAL was performed. The time period was up to January 31, 2024. All animal studies investigating the stem cell therapy for treating DPN were included. A random-effects model to combine effect sizes in our meta-analysis was applied. 29 out of the 5431 records met the eligibility criteria. In these studies, stem cell therapy improved motor and sensory nerve conduction velocity, compound muscle action potential (CMAP), and sciatic nerve blood flow. Post-treatment, mechanical and thermal nociceptive thresholds decreased. Rats had significant improvement in axonal circularity, nerve growth factor, and transforming growth factor beta 1; mice had significant increase in weight, CMAP, and angiopoietin 1. The stem cell subgroup analysis showed that dental pulp stem cells had the greatest effects across all parameters, while bone marrow mononuclear cells had strong biochemical responses. Stem cell therapy demonstrates promising efficacy in ameliorating neuropathic symptoms in DPN animal models. Human patient studies and targeted treatment procedures for specific neuropathic disorders are advocated to improve therapeutic outcomes. © 2024 International Brain Research Organization (IBRO)
Related Docs
1. Human Studies of the Efficacy and Safety of Stem Cells in the Treatment of Diabetic Peripheral Neuropathy: A Systematic Review and Meta-Analysis, Stem Cell Research and Therapy (2024)
2. Bone Tissue Engineering Using Human Cells: A Comprehensive Review on Recent Trends, Current Prospects, and Recommendations, Applied Sciences (Switzerland) (2019)
3. The Role of Dental-Derived Stem Cell-Based Therapy and Their Derived Extracellular Vesicles in Post-Covid-19 Syndrome-Induced Tissue Damage, Stem Cell Reviews and Reports (2024)
Experts (# of related papers)
Vafa Rahimi-Movaghar (1)
SeyedMohamad Hosseini Hooshiyar (1)